美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)

0.1350

0.0000

成交量：- -

成交额：22.41

市值：93.90万

市盈率：0.00

高：0.1350

开：0.1350

低：0.1350

收：0.1350

52周最高：0.6500

52周最低：0.0375

股本：695.57万

流通股本：695.57万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-33.1842

净资产收益率：--

总资产收益率：-59.70%

市净率：-0.00

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.scilexholding.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Scilex Holding Company于2019年2月在特拉华州成立。该公司是一家创新型创收公司，专注于收购、开发和商业化用于治疗急性和慢性疼痛的非阿片类药物管理产品。该公司认为，该公司创新的非阿片类药物产品组合有潜力提供有效的疼痛管理疗法，可以对患者的生活产生变革性影响。该公司以非阿片类药物疗法治疗急性和慢性疼痛患者的高未满足需求和大市场机会的适应症为目标，致力于推进和改善患者预后。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SCLXW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCLXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLXW\",,,,,undefined,":{"symbol":"SCLXW","market":"US","secType":"STK","nameCN":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)","latestPrice":0.135,"timestamp":1773933937508,"preClose":0.135,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":6955697,"shares":6955697,"eps":-33.1842,"marketStatus":"交易中","change":0,"latestTime":"03-19 11:25:37 EDT","open":0.135,"high":0.135,"low":0.135,"amount":22.41,"amplitude":0,"askPrice":0.1348,"askSize":99,"bidPrice":0.1302,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-33.1842,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773950400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.135,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLXW\",,,,,undefined,":{"symbol":"SCLXW","floatShares":6955697,"roa":"-59.70%","roe":"--","lyrEps":0,"shares":6955697,"dividePrice":0,"high":0.135,"amplitude":0,"preClose":0.135,"low":0.135,"week52Low":0.0375,"pbRate":"-0.00","psRate":"0.02","week52High":0.65,"institutionHeld":0,"latestPrice":0.135,"committee":-0.98,"eps":-33.1842,"divideRate":0,"volume":0,"delay":0,"ttmEps":-33.1842,"open":0.135,"prevYearClose":0.0949,"prevWeekClose":0.1352,"prevMonthClose":0.1494,"prevQuarterClose":0.0949,"fiveDayClose":0.1352,"twentyDayClose":0.1525,"sixtyDayClose":0.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCLXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCLXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCLXW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.scilexholding.com","stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0982},{"period":"3month","weight":-0.2059},{"period":"6month","weight":-0.6625},{"period":"1year","weight":0.5},{"period":"ytd","weight":0.4226}],"compareEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0222},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.179},{"period":"ytd","weight":-0.03}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scilex Holding Company于2019年2月在特拉华州成立。该公司是一家创新型创收公司，专注于收购、开发和商业化用于治疗急性和慢性疼痛的非阿片类药物管理产品。该公司认为，该公司创新的非阿片类药物产品组合有潜力提供有效的疼痛管理疗法，可以对患者的生活产生变革性影响。该公司以非阿片类药物疗法治疗急性和慢性疼痛患者的高未满足需求和大市场机会的适应症为目标，致力于推进和改善患者预后。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":1.386497},{"month":2,"riseRate":0.4,"avgChangeRate":-0.126746},{"month":3,"riseRate":0.4,"avgChangeRate":-0.018505},{"month":4,"riseRate":0.6,"avgChangeRate":0.094252},{"month":5,"riseRate":0.2,"avgChangeRate":-0.09574},{"month":6,"riseRate":0.6,"avgChangeRate":0.094055},{"month":7,"riseRate":0.8,"avgChangeRate":0.891221},{"month":8,"riseRate":0.2,"avgChangeRate":-0.142129},{"month":9,"riseRate":0.2,"avgChangeRate":-0.220439},{"month":10,"riseRate":0.8,"avgChangeRate":0.142407},{"month":11,"riseRate":0.6,"avgChangeRate":0.046068},{"month":12,"riseRate":0,"avgChangeRate":-0.285719}],"exchange":"NASDAQ","name":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)","nameEN":"SCILEX HOLDING COMPANY C/WTS 10/11/2027(TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SCLXW\",market:\"US\",,,undefined,":null}}